Clinical Trial

Levetiracetam Prophylaxis in Brain Tumor Resection Pilot

Study acronym: LeviTaTe Pilot
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated October 23, 2024 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate feasibility of a double-blind randomized controlled trial for levetiracetam prophylaxis for prevention of seizure in the perioperative phase of brain tumor resection.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-06-01; most recent amendment 2024-10-21.
Trial Details
NCT Number NCT05897658
Lead Sponsor Hamilton Health Sciences Corporation
Collaborators: McMaster University
Conditions Seizures, Brain Tumor
Enrollment 70 participants
Start Date 2025-03
Primary Completion 2026-03 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2024-10-23